The NASH Study
for Nonalcoholic Steatohepatitis

Challenge

  • Patients need to be educated about the importance of treating NASH, often termed a “silent liver disease” and motivated to attend study visits with lengthy time in between each visit.

Solutions

  • Factoring in the needs of each country, a targeted program was developed to address the importance of study visits, clinical trial research and overall NASH management. Point of contact in between study visits enhances compliance and keeps the study top of mind with patients.

Result

  • Currently being launched to countries as they become activated, sites are beginning to introduce and take advantage of the program as patients are randomized into the study.

Project Scope: Retain adults with nonalcoholic steatohepatitis participating in this worldwide study taking place in 23 countries.

Back to list image retention, global, metabolic, renal    

Other Portfolio Pieces: